Mustang Bio (MBIO) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free MBIO Stock Alerts $0.35 -0.01 (-2.78%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWorcester biotech down to 11 employees after asset sale stallsbizjournals.com - April 22 at 7:47 PMBiotech cites federal review of deal with Chinese firm in latest staff cutsbizjournals.com - April 16 at 9:03 AMMustang Bio stock tumbles 27% amid news of mass layoffsmsn.com - April 15 at 5:59 PMMustang Bio announces major workforce reductioninvesting.com - April 14 at 11:56 AMMustang Bio to Cut Global Headcount by 81%marketwatch.com - April 12 at 8:56 PMMustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseasesglobenewswire.com - March 28 at 9:00 AMMustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlightsglobenewswire.com - March 11 at 4:05 PMMustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Ra2-targeted CAR T-Cells in High-Grade Gliomatmcnet.com - March 7 at 9:09 AMWhy Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarketmarkets.businessinsider.com - March 7 at 9:09 AMMustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Gliomaglobenewswire.com - March 7 at 7:30 AMMustang Bio Inc (MBIO)uk.investing.com - February 13 at 2:36 PMMustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conferencefinance.yahoo.com - January 11 at 9:29 AMMustang Bio Inc MBIOmorningstar.com - January 6 at 12:54 AMMustang Bio Stock (NASDAQ:MBIO) Dividends: History, Yield and Datesbenzinga.com - December 27 at 10:10 PMMBIO Mustang Bio, Inc.seekingalpha.com - December 22 at 10:10 AMMustang Bio files to sell 2.74M shares of common stock for holdersmsn.com - December 12 at 1:26 PMMustang Bio’s Positive Financial Performance and Promising Clinical Developments Drive Buy Ratingmarkets.businessinsider.com - November 15 at 8:45 PMMustang Bio, Inc.: Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlightsfinanznachrichten.de - November 15 at 3:44 PMMustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meetingfinance.yahoo.com - November 2 at 10:51 AMMustang Bio Announces Closing of $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - October 30 at 3:45 PMMustang Bio Shares Rise 13% After FDA Acceptance of IND Applicationmarketwatch.com - October 26 at 2:44 PMMustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade Astrocytomafinance.yahoo.com - October 26 at 9:44 AMCantor Fitzgerald Reiterates Mustang Bio (MBIO) Overweight Recommendationnasdaq.com - August 25 at 4:43 AMMustang Bio, Inc.: Mustang Bio Reports Second Quarter 2023 Financial Results and Recent Corporate Highlightsfinanznachrichten.de - August 15 at 4:05 PMWhat 4 Analyst Ratings Have To Say About Mustang Biomarkets.businessinsider.com - August 15 at 4:05 PMH.C. Wainwright Sticks to Their Buy Rating for Mustang Bio (MBIO)markets.businessinsider.com - August 15 at 10:02 AMMBIO - Mustang Bio, Inc.finance.yahoo.com - July 29 at 1:17 PMMustang Bio (MBIO) Price Target Decreased by 35.40% to 18.62msn.com - July 6 at 1:33 AMH.C. Wainwright Remains a Buy on Mustang Bio (MBIO)markets.businessinsider.com - June 16 at 7:47 AMBTIG Keeps Their Buy Rating on Mustang Bio (MBIO)markets.businessinsider.com - June 16 at 7:47 AMMustang (MBIO) Up 9% on Rare Blood Cancer Study's Upbeat Datafinance.yahoo.com - June 13 at 3:31 PMMustang Bio (MBIO) Gets a Buy from H.C. Wainwrightmarkets.businessinsider.com - June 12 at 7:02 PMWall Street Analysts Think Mustang Bio, Inc. (MBIO) Could Surge 331.15%: Read This Before Placing a Betfinance.yahoo.com - June 12 at 7:02 PMMustang Bio (NASDAQ: MBIO)fool.com - June 3 at 1:01 PMWall Street Analysts Believe Mustang Bio, Inc. (MBIO) Could Rally 711.55%: Here's is How to Tradefinance.yahoo.com - May 26 at 3:40 PMMustang Bio Announces Strategic Manufacturing Partnership and Portfolio Updatesfinance.yahoo.com - May 18 at 8:12 AMHC Wainwright & Co. Reiterates Mustang Bio (MBIO) Buy Recommendationmsn.com - May 16 at 9:28 AMMustang Bio Stock (NASDAQ:MBIO), Insider Trading Activitybenzinga.com - May 15 at 3:07 PMAnalysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Mustang Bio (MBIO) and Cidara Therapeutics (CDTX)markets.businessinsider.com - May 15 at 10:07 AMMustang Bio GAAP EPS of -$2.06 beats by $0.95msn.com - May 14 at 2:03 PMMustang Bio, Inc.: Mustang Bio Reports First Quarter 2023 Financial Results and Recent Corporate Highlightsfinanznachrichten.de - May 13 at 8:05 AMMustang Bio: Q1 Earnings Insightsmsn.com - May 12 at 8:48 PMMustang Bio, Inc.: Mustang Bio Reports Full-Year 2022 Financial Results and Recent Corporate Highlightsfinanznachrichten.de - March 30 at 11:13 PMFortress Biotech Reports Record 2022 Financial Results and Recent Corporate Highlightsfinance.yahoo.com - March 30 at 6:12 PMMustang Bio GAAP EPS of -$0.75 beats by $0.01msn.com - March 29 at 5:06 PMMustang Bio Reports Full-Year 2022 Financial Results and Recent Corporate Highlightsfinance.yahoo.com - March 29 at 5:06 PMFord cuts price of Mustang Mach-E to compete with Tesla, offers deal to recent buyers toousatoday.com - February 17 at 7:19 PMMustang Bio Provides CAR T Cell Therapy Portfolio Updates and 2023 Anticipated Milestonesfinance.yahoo.com - December 19 at 9:57 AMMustang Bio, Inc.: Mustang Bio Reports Third Quarter 2022 Financial Results and Recent Corporate Highlightsfinanznachrichten.de - November 15 at 4:51 PMMustang Bio Unchanged on Test Resultsbaystreet.ca - October 6 at 11:08 AM Get Mustang Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for MBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… MBIO Media Mentions By Week MBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBIO News Sentiment▼0.360.43▲Average Medical News Sentiment MBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBIO Articles This Week▼10▲MBIO Articles Average Week Get Mustang Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for MBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NEXI News EVOK News CING News VRPX News BPTS News GOVX News KTRA News ARDS News THAR News ZVSA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MBIO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mustang Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
